Amphoterin includes a sequence motif which is homologous to the Alzheimer's β-amyloid peptide (Aβ), forms amyloid fibrils in vitro, and binds avidly to Aβ

被引:26
|
作者
Kallijärvi, J
Haltia, M
Baumann, MH
机构
[1] Univ Helsinki, Prot Chem Unit, Inst Biomed, Biomedicum Helsinki, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland
关键词
D O I
10.1021/bi002095n
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many of the proteins associated with amyloidoses have been found to share structural and sequence similarities, which are believed to be responsible for their capability to form amyloid fibrils. Interestingly, some proteins seem to be able to form amyloid-like fibrils although they are not associated with amyloidoses. This indicates that the ability to form amyloid fibrils may be a general property of a greater number of proteins not associated with these diseases. In the present work, we have searched for amyloidogenic consensus sequences in two current protein/peptide databases and show that many proteins share structures which can be predicted to form amyloid. One of these potentially amyloidogenic proteins is amphoterin (also known as HMG-1), involved in neuronal development and a ligand for the receptor for advanced glycation end products (RAGE). It contains an amyloidogenic peptide fragment which is highly homologous to the Alzheimer's amyloid beta -peptide. If enzymatically released from the native protein, it forms amyloid-like fibrils which are visible in electron microscopy, exhibit apple green birefringence under polarized light after Congo red staining, and increases thioflavin T fluorescence. This fragment also shows high affinity to A beta as a free peptide or while part of the native protein. Our results support the hypothesis that the potential to form amyloid is a common characteristic of a number of proteins, independent of their relation to amyloidoses, and that this potential can be predicted based on the physicochemical properties of these proteins.
引用
收藏
页码:10032 / 10037
页数:6
相关论文
共 50 条
  • [31] Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid β-peptide by microglial cells
    Chung, HY
    Brazil, MI
    Soe, TT
    Maxfield, FR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (45) : 32301 - 32308
  • [32] The Alzheimer's amyloid β-peptide (Aβ) binds a specific DNA Aβ-interacting domain (AβID) in the APP, BACE1, and APOE promoters in a sequence-specific manner: Characterizing a new regulatory motif
    Maloney, Bryan
    Lahiri, Debomoy K.
    GENE, 2011, 488 (1-2) : 1 - 12
  • [33] Cryogenic solid state NMR studies of fibrils of the Alzheimer's disease amyloid-β peptide: perspectives for DNP
    Lopez del Amo, Juan-Miguel
    Schneider, Dennis
    Loquet, Antoine
    Lange, Adam
    Reif, Bernd
    JOURNAL OF BIOMOLECULAR NMR, 2013, 56 (04) : 359 - 363
  • [34] Structural and dynamic features of Alzheimer's Aβ peptide in amyloid fibrils studied by site-directed spin labeling
    Török, M
    Milton, S
    Kayed, R
    Wu, P
    McIntire, T
    Glabe, CG
    Langen, R
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (43) : 40810 - 40815
  • [35] Cryogenic solid state NMR studies of fibrils of the Alzheimer’s disease amyloid-β peptide: perspectives for DNP
    Juan-Miguel Lopez del Amo
    Dennis Schneider
    Antoine Loquet
    Adam Lange
    Bernd Reif
    Journal of Biomolecular NMR, 2013, 56 : 359 - 363
  • [36] Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid
    Conway, KA
    Harper, JD
    Lansbury, PT
    BIOCHEMISTRY, 2000, 39 (10) : 2552 - 2563
  • [37] Inhibition of cytotoxicity and amyloid fibril formation by a D-amino acid peptide that specifically binds to Alzheimer's diseaseamyloid peptide
    Wiesehan, K.
    Stoehr, J.
    Nagel-Steger, L.
    van Groen, T.
    Riesner, D.
    Willbold, D.
    PROTEIN ENGINEERING DESIGN & SELECTION, 2008, 21 (04): : 241 - 246
  • [38] Anti-Parkinsonian agents have anti-amyloidogenic activity for Alzheimer's β-amyloid fibrils in vitro
    Ono, K
    Hasegawa, K
    Naiki, H
    Yamada, M
    NEUROCHEMISTRY INTERNATIONAL, 2006, 48 (04) : 275 - 285
  • [39] Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's β-amyloid fibrils in vitro
    Ono, K
    Hasegawa, K
    Naiki, H
    Yamada, M
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2004, 1690 (03): : 193 - 202
  • [40] Additive Toxicity of β-Amyloid by a Novel Bioactive Peptide In Vitro: Possible Implications for Alzheimer's Disease
    Garcia-Rates, Sara
    Lewis, Matthew
    Worrall, Rosemary
    Greenfield, Susan
    PLOS ONE, 2013, 8 (02):